FDA approves Eylea to treat all stages of diabetic retinopathy

Currently used to treat diabetic macular edema, Eylea recently gained FDA approval for treating all stages of diabetic retinopathy. Eylea works as a “vascular endothelial growth factor (VEGF)” inhibitor by stopping the growth of abnormal blood vessels in the eye. It also reduces swelling and leakage, which are what lead to vision loss. Clinical trials […]

Avastin more effective for diabetic macular edema

A recent study did a comparison of the three top drugs used to treat diabetic macular edema. Researchers took a look at Avastin, Eylea and Lucentis and while all three drugs were equally effective in improving vision in patients who had slight vision impairment, Eylea was found to be more effective in treating patients with […]